In 2011, Mark Smith was working on a Ph.D. in microbiology at the Massachusetts Institute of Technology when his friend's cousin—we'll call him Steve—was diagnosed with C. difficile. Known by the shorthand C. diff, it is now the most common hospital-acquired bacterial infection, and, as the name implies, it's difficult to treat. Patients have near-constant severe diarrhea and bleeding from the bowels that can last for months, or even years. Many sufferers can't hold a job because they're housebound.
Like many C. diff patients, Steve wasn't getting much relief from antibiotics. There are currently between 500,000 and 3 million cases of C. diff. Of those, a small but significant portion—perhaps as many as 120,000—continue to have symptoms after three rounds of standard treatment. But Steve knew of something that might work. He'd researched fecal transplants, a bizarre-sounding therapy in which patients receive an enema of someone else's feces, in the hopes that the healthy sample will reintroduce the bacteria lost in the sick patient.
It sounds disgusting, but given the alternative—colon removal—fecal transplants can be a godsend.
It sounds disgusting, but given the alternative—colon removal—fecal transplants can be a godsend for C. diff patients who don't respond to the standard battery of antibiotics. The raw material is abundant and the procedure is easy. Doctors, health officials, researchers, and entrepreneurs have begun to see the potential of fecal transplants to treat not just C. diff, but perhaps a multitude of ailments, from irritable bowel syndrome to chronic constipation.
Are healthy gut bacteria the key to weight loss? Read Mother Jones' explanation here.
Steve asked Smith about the procedure, and Smith read the literature. As a treatment option, a fecal transplant looked great, but at the time, Steve couldn't find any doctor willing to help. The stool donor would need to be screened for other infectious diseases, and physicians were reluctant to order diagnostic tests for someone who wasn't sick. If the tests found something, the doctor would be responsible for treating the donor as a patient.
"I felt like I was part of a system that was failing," Smith told me in an email. "We had a serious public health problem and we already knew the solution to it. Yet somehow the solution wasn't getting out to patients."
After suffering for a year and a half, Steve persuaded his roommate to donate some stool. Without a doctor in sight, he used an enema to perform the transplant himself in his apartment. He started to feel better almost immediately.
On YouTube videos and on a site called The Power of Poop, patients share guides and tips for doing transplants in their homes.
Steve isn't the only patient to have attempted a DIY fecal transplant. On YouTube videos and on a site called The Power of Poop, patients share guides and tips for doing transplants in their homes.
In one scrappy video that's been viewed 38,000 times, a mother who goes by "HomeFMT" (for "fecal microbiota transplant," the technical term for the procedure) stands at a bathroom sink listing what you'll need—a strainer, a plastic spoon, a blender—then demonstrates how to force the poop through a sieve before putting it in an enema for her daughter.
The girl was sick, the mom explains—she doesn't say with what—and she tried everything. But after one dose of mommy's poop, the symptoms were gone within 24 hours. She clutches the full enema as if it were a family heirloom. "Fecal transplant has truly been our miracle," she says, "and hopefully it will be yours."
But adding a foreign agent into your body can be dangerous. Along with the "good" bacteria in fecal matter, there can be pathogens, as well. Clinics can test samples for disease so that patients don't end up even more sick than before, but that requires a lab and a trained staff.
Tracy Mac, the founder of The Power of Poop site, told me by email that "ninety-nine percent of people I have encountered want to use a doctor for peace of mind and are forced to DIY," because they can't get treatment in hospitals.
After Steve's ordeal, Smith began talking to a friend, James Burgess, who was then working for the Bill and Melinda Gates Foundation. The pair considered starting a company to provide feces to doctors, but quickly backed off the idea. The bacterial makeup of a person's stool changes over time, making it hard to provide a consistent product. What's more, the efficacy of fecal transplants is somewhat of a mystery. There's a vast diversity of bacteria in the colon—more than the rest of the human body—yet no one knows which bacteria make a healthy person's poop restore the bacteria in a sick person's colon, or even whether the key component is dead or alive.
Some people believe poop should be regulated like blood or organs. Others have suggested the FDA should treat it as a biologic drug, like a vaccine.
"It didn't really feel like a high-value business to us," Burgess explains. "But it felt important from a public health perspective." So in 2012, they formed OpenBiome, a nonprofit stool bank at MIT that collects, screens, and sells frozen, transplant-ready fecal matter to hospitals at cost (about $250 per dose). With more than 70 hospitals around the United States using their stool to treat patients, it's currently the largest of a family of nonprofit stool banks, having shipped more than 840 treatments to 87 hospitals in 30 states and the District of Columbia.
But whether OpenBiome will be allowed to continue its work now depends on the Food and Drug Administration. The agency has recently taken the first steps to regulate fecal matter—and the medical community is divided over the right approach. Some doctors and researchers, like OpenBiome's founders, believe it should be considered a tissue, like blood or organs. Others have suggested the FDA should treat it as a biologic drug, like a vaccine.
As a tissue, poop could be traded through banks, just like blood or sperm is now, with tests in place to make sure the samples are disease-free. This approach would make raw, the stuff readily available for patients who needed it. Regulating poop as a drug would subject it to a higher standard of safety tests by submitting it to clinical trials and generate data which could benefit the entire field. But critics of that approach (like Smith) say it will limit the supply of this therapy to companies that can afford to undergo the trials.